Fig. 3: Kidney and liver function tests and animal weights of different experimental groups at different experimental periods. | Gene Therapy

Fig. 3: Kidney and liver function tests and animal weights of different experimental groups at different experimental periods.

From: Aptamer-targeted anti-miR RNA construct based on 3WJ as a new approach for the treatment of chronic kidney disease in an experimental model

Fig. 3

Kidney function tests (a, b), liver function tests (c, d), hemoglobin (e), EPO (f), weight (g) Data are presented as mean ± SD. n = 5. a significantly different from control mice, b significantly different from untreated CKD mice, c significantly different from CKD-3WJ mice by ANOVA followed by Bonferroni post hoc test (p < 0.05) at the same time point. *: significantly different from the first week’s results, #: significantly different from the second week’s results by ANOVA followed by Bonferroni post hoc test (p < 0.05). ALT alanine aminotransferase, AST aspartate aminotransferase, EPO Erythropoietin.

Back to article page